On behalf of the Organising Committee, it gives me great pleasure to invite you to participate in the upcoming 15th Asian Epigenomics Meeting (AEM15), from 24 - 25 February 2021. Due to the ongoing pandemic and travel restrictions, this will be a virtual (online) meeting.
The Asian Epigenomics Meeting series was created in 2006 as a showcase for cutting-edge Asian science, and to seed collaborations and exchange of ideas between world-leading epigenetics researchers in Asia and beyond. These meetings cover a range of topics from basic biochemistry and biophysics of chromatin to gene regulation in development and disease. The series is hosted on a rotating basis by the six member countries: China, India, Japan, Singapore, South Korea and Taiwan.
This year, the meeting is hosted by Singapore. AEM 2021’s goal is to bring together a multi-disciplinary group of scientists from all over Asia to present and exchange break-through ideas with the broader global community and leading subject experts. This conference covers global aspects of epigenomics ranging from fundamental issues to practical applications, and hence will add value to anyone interested in the future of Epigenetics!
We look forward to sharing new and exciting results in epigenomics, and to an excellent meeting with scientific discussions and perspectives from around the world. We welcome you to this conference and look forward to your participation.
Organising Committee Chair
15th Asian Epigenomics Meeting
The Genome Institute of Singapore (GIS) is an institute of the Agency for Science, Technology and Research (A*STAR). It has a global vision that seeks to use genomic sciences to achieve extraordinary improvements in human health and public prosperity. Established in 2000 as a centre for genomic discovery, the GIS pursues the integration of technology, genetics and biology towards academic, economic and societal impact, with a mission to "read, reveal, and (w)rite DNA for a better Singapore and world".
Key research areas at the GIS include Precision Medicine & Population Genomics, Genome Informatics, Spatial & Single Cell Systems, Epigenetic & Epitranscriptomic Regulation, Genome Architecture & Design, and Sequencing Platforms. The genomics infrastructure at the GIS is also utilised to train new scientific talent, to function as a bridge for academic and industrial research, and to explore scientific questions of high impact.
For more information about GIS, please visit www.a-star.edu.sg/gis
The Agency for Science, Technology and Research (A*STAR) is Singapore's lead public sector R&D agency. Through open innovation, we collaborate with our partners in both the public and private sectors to benefit the economy and society. As a Science and Technology Organisation, A*STAR bridges the gap between academia and industry. Our research creates economic growth and jobs for Singapore, and enhances lives by improving societal outcomes in healthcare, urban living, and sustainability. A*STAR plays a key role in nurturing scientific talent and leaders for the wider research community and industry. A*STAR’s R&D activities span biomedical sciences to physical sciences and engineering, with research entities primarily located in Biopolis and Fusionopolis. For ongoing news, visit www.a-star.edu.sg.